Action Tempest Therpeutics - TPST

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

0,8299

Prix Achat

0,8143

Prix Vente

0,85

Volume échangé

19 285

0,00 Fourchette du Jour 0,00

0,6986 Plage de 52 semaines 6,00

Cap du marché

36,219M

Clôture Veille

0,8067

Ouverture

Dernière Transaction

100

0.8299

(formt)

Dernière heure de transaction

14:12:07

Volume financier

VWAP

Volume moyen (3 m)

1 301 561

Actions en circulation

43 642 072

Rendement du Dividende

Ratio Cours sur Bénéfices

-1,20

Bénéfice par action (BPA)

-0,68

Chiffre d'affairess

Bénéfice net

-29,49M

Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.tempesttx.com

Siège social

Wilmington, Delaware, USA

Fondé

Tempest Therpeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker TPST. Le dernier cours de clôture d'Tempest Therpeutics était de US$0,81. Au cours de la dernière année, les actions de Tempest Therpeutics ont été négociées dans une fourchette de prix de US$ 0,6986 à US$ 6,00.

Tempest Therpeutics compte actuellement 43 642 072 actions en circulation. La capitalisation boursière d'Tempest Therpeutics est de US$35,21 million. Tempest Therpeutics a un ratio cours/bénéfice (ratio PE) de -1.20.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.1001	-10.7634408602	0.93	0.93375	0.7964	758832	0.86329509	CS
4	-0.0601	-6.75280898876	0.89	0.97	0.7964	873525	0.89681821	CS
12	-0.0601	-6.75280898876	0.89	1.05	0.6986	1301561	0.87538484	CS
26	-0.5701	-40.7214285714	1.4	1.59	0.6986	2261157	1.03117335	CS
52	-3.1001	-78.8829516539	3.93	6	0.6986	2083746	1.60694278	CS
156	-2.3601	-73.9843260188	3.19	9.77	0.17	1727365	4.11791067	CS
260	-12.9801	-93.9905865315	13.81	41	0.17	1458616	4.61281762	CS

TPST - Frequently Asked Questions (FAQ)

What is the current Tempest Therpeutics share price?

The current share price of Tempest Therpeutics is US$ 0,8299

How many Tempest Therpeutics shares are in issue?

Tempest Therpeutics has 43 642 072 shares in issue

What is the market cap of Tempest Therpeutics?

The market capitalisation of Tempest Therpeutics is USD 35,21M

What is the 1 year trading range for Tempest Therpeutics share price?

Tempest Therpeutics has traded in the range of US$ 0,6986 to US$ 6,00 during the past year

What is the PE ratio of Tempest Therpeutics?

The price to earnings ratio of Tempest Therpeutics is -1,2

What is the reporting currency for Tempest Therpeutics?

Tempest Therpeutics reports financial results in USD

What is the latest annual profit for Tempest Therpeutics?

The latest annual profit of Tempest Therpeutics is USD -29,49M

What is the registered address of Tempest Therpeutics?

The registered address for Tempest Therpeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Tempest Therpeutics website address?

The website address for Tempest Therpeutics is www.tempesttx.com

Which industry sector does Tempest Therpeutics operate in?

Tempest Therpeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ENVBEnveric Biosciences Inc	US$ 3,2401 (174,58%)	41,31M
QVCGBQVC Group Inc	US$ 11,40 (124,41%)	2,45M
IPAImmunoPrecise Antibodies Ltd	US$ 0,6187 (66,36%)	3,69M
LSBKLake Shore Bancorp Inc	US$ 25,47 (59,11%)	9
BSBKBogota Financial Corporation	US$ 12,40 (56,57%)	282
ADVMAdverum Biotechnologies Inc	US$ 1,73 (-58,81%)	21
CSPICSP Inc	US$ 9,12 (-41,87%)	13
SRBKSR Bancorp Inc	US$ 7,01 (-41,83%)	11
BSMWInvesco BulletShares 2032 Municipal Bond ETF	US$ 15,01 (-40,48%)	1
CSBRChampions Oncology Inc	US$ 6,06 (-36,74%)	15
ENVBEnveric Biosciences Inc	US$ 3,2401 (174,58%)	41,31M
CGTXCognition Therapeutics Inc	US$ 0,5363 (3,81%)	24,67M
HCTIHealthcare Triangle Inc	US$ 0,58 (52,63%)	21,26M
PITAHeramba Electric PLC	US$ 0,5431 (47,18%)	21,09M
ONVOOrganovo Holdings Inc	US$ 1,54 (21,26%)	13,44M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Tempest Therpeutics Inc (TPST)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Tempest Therpeutics Inc

TPST Dernières nouvelles

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form EFFECT - Notice of Effectiveness

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form EFFECT - Notice of Effectiveness

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

TPST - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Tempest Therpeutics Inc (TPST) Cours

Tempest Therpeutics Inc (TPST)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Tempest Therpeutics Inc

TPST Dernières nouvelles

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form EFFECT - Notice of Effectiveness

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form EFFECT - Notice of Effectiveness

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

TPST - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités